Methods for the Collection of Resource Use Data within Clinical Trials: A Systematic Review of Studies Funded by the UK Health Technology Assessment Program

被引:70
作者
Ridyard, Colin H. [1 ]
Hughes, Dyfrig A. [1 ]
机构
[1] Bangor Univ, Ctr Econ & Policy Hlth, Inst Med & Social Care Res, Bangor LL57 1UT, Gwynedd, Wales
基金
英国医学研究理事会;
关键词
clinical trials; cost analysis; economic evaluation; health technology assessment; RANDOMIZED CONTROLLED-TRIAL; SEROTONIN REUPTAKE INHIBITORS; COST-EFFECTIVENESS; ECONOMIC-EVALUATION; PRIMARY-CARE; CHILDREN; POPULATION; THERAPY;
D O I
10.1111/j.1524-4733.2010.00788.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background: The UK Health Technology Assessment (HTA) program funds trials that address issues of clinical and cost-effectiveness to meet the needs of the National Health Service (NHS). The objective of this review was to systematically assess the methods of resource use data collection and costing; and to produce a best practice guide for data capture within economic analyses alongside clinical trials. Methods: All 100 HTA-funded primary research papers published to June 2009 were reviewed for the health economic methods employed. Data were extracted and summarized by: health technology assessed, costing perspective adopted, evidence of planning and piloting, data collection method, frequency of data collection, and sources of unit cost data. Results: Ninety-five studies were identified as having conducted an economic analysis, of which 85 recorded patient-level resource use. The review identified important differences in how data are collected. These included: a priori evidence of analysts having identified important cost drivers; the piloting and validation of patient-completed resource use questionnaires; choice of costing perspective; and frequency of data collection. Areas of commonality included: the extensive use of routine medical records and reliance on patient recall; and the use of standard sources of unit costs. Conclusion: Economic data collection is variable, even among a homogeneous selection of trials designed to meet the needs of a common organization (NHS). Areas for improvement have been identified, and based on our findings and related reviews and guidelines, a checklist is proposed for good practice relating to economic data collection within clinical trials.
引用
收藏
页码:867 / 872
页数:6
相关论文
共 41 条
[41]  
Wilson BJ, 2005, HEALTH TECHNOL ASSES, V9, P1